menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • Study Endpoints
        • Cardiac safety and efficacy endpoint solutions for all phases, anywhere in the world.

        • Collect continuous ECG data in site-based or hybrid trials with our flexible solutions and patient-friendly devices.

        • Collect and centrally analyze accurate, consistent, quality blood pressure data from site-based to hybrid trials.

        • Monitor every heartbeat with precision to assess safety and efficacy throughout your site-based or hybrid clinical trial.

        • Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial.

        • Leverage our key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

        • Make your clinical trials easier, faster, more engaging and accessible to all.

        • Deliver reliable, scalable, and regulatory-ready eCOA for global Central Nervous System (CNS) trials.

        • Accelerate your clinical trial setup with Clario’s pre-validated and configured eCOA assessments.

        • Expert guidance for capturing high-quality, regulatory compliant data from the right participants, at the right time, in clinic or at home.

        • Improve data accuracy and reduce variability in scoring with Clario’s training solutions.

        • Your trusted partner for the richest eCOA endpoint data in your clinical trial.

        • Monitor Suicide Ideation and Behavior (SIB) in clinical trials effectively with Clario’s suicide assessment tool, eC-SSRS.

        • Enjoy flexible, fast and confidential site assessments at home.

        • Enhance your ePRO data with photo and audio capture.

        • Accelerate drug development and reduce risk with Clario’s comprehensive medical imaging core lab services.

        • The Clario team includes medical imaging experts and globally recognized key opinion leaders (KOLs) representing multiple disciplines.

        • Clario’s Image Redact AI automatically redacts sensitive patient identifiers from videos, photos and PDFs.

        • Secure accurate results, streamline your processes, and meet your unique needs with our imaging platform.

        • Leverage our full range of medical imaging and diagnostic imaging modalities, including CT Scans, Endoscopy, MRIs, and more.

        • Securely collect, store, and share de-identified images for compliance with 21 CFR Part 11 and EU GDPR standards.

        • Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

        • The Opal V2R® is a research grade wearable sensor that delivers meaningful outcomes and richer insights.

        • Explore more than 750 scientific publications that reflect the technical and clinical applications of Clario’s Opal® System.

        • Everything you need for high quality, low variability pulmonary function data and high patient compliance for clinical trials.

        • Improve your data quality, monitor for proper technique and leverage the power of AI to make interpretation of spirometry tests easier, faster and more consistent.

        • Centralized, on-site pulmonary function testing for clinical trials.

        • Remote spirometry testing for respiratory clinical trials.

        • Assess cough frequency, cough severity and other lung sounds such as crackles or rhonchi for clinical trials.

        • Assess the capacity of the lungs for effective gas transfer.

        • Advanced, cloud-native technologies and clinical trial software to screen, clean, QC and assess complicated data.

        • Collect, centralize and manage participant screening and eligibility data with customized workflows.

        • Boost stakeholder insights with business intelligence (BI) tools, analytics for endpoint and safety risks, and data exchange solutions.

        • Securely collect, store and share compliant images in the cloud to keep clinical trial sponsors and labs informed.

    • Segments
    • Study Phases
    • Technology
  • Therapeutic Areas
    • Cardiovascular & Metabolic Icon RGBCardiovascular & Metabolic
    • Dermatology Icon RGBDermatology
    • Type 2 Diabetes and Obesity iconDiabetes and Obesity
    • Gastroenterology Icon RGBGastroenterology
    • Hepatology Icon RGBHepatology
    • Infectious Disease Icon RGBInfectious Diseases
    • Muskoskeletal Icon RGBMusculoskeletal
    • Neuroscience Icon RGBNeuroscience
      • Neuroscience Indications
    • Oncology Icon RGBOncology
    • Ophthalmology Icon RGBOphthalmology
    • Respiratory Solutions IconRespiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values and Culture
  • Support
    • Customer Support
    • In-Country Customer Support
  • Solutions
    • Study Endpoints
      • Cardiac Solutions
        • Cardiac Solutions
        • Arrhythmia Analysis
        • Blood Pressure Services
        • ECG — On-site to DCT and Phase I-IV
        • Phase I/TQT Cardiac Assessment
        • Regulatory Consultation and Statistical Analysis Expertise
      • Clinical Adjudication
      • eCOA
        • eCOA Clinical Trials
        • eCOA Neuroscience
        • eCOA Rapid Start
        • eCOA Science Services
        • eCOA Rater and Participant Training
        • eCOA Rescue Studies
        • Suicidal Ideation
        • eCOA Live
        • eCOA Multimedia
      • Medical Imaging
        • Medical Imaging
        • Image Redact AI
        • Imaging Platform
        • Medical Imaging Science Team
        • Modalities
        • SMART Submit
      • Precision Motion
        • Precision Motion for Clinical Trials
        • Precision Motion for Research
        • Precision Motion: Scientific Publications
      • Respiratory Solutions
        • Respiratory Solutions
        • Respiratory Solutions for Healthcare Providers
        • Site-Based Spirometry
        • Virtual Home Spirometry
        • Cough and Lung Sounds
        • Diffusing Capacity (DLCO)
      • Trial Enablement
        • Trial Enablement
        • Eligibility Solution
        • Reporting & Analytics
        • Source Document Manager
    • Segments
      • Biotechs
      • CROs
      • Pharma
    • Study Phases
      • Phase I
      • Phase II/III
    • Technology
      • Artificial Intelligence (AI)
      • Hybrid Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Diabetes and Obesity
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
      • Dementias
      • Headache Disorders
      • Movement Disorders
      • Multiple Sclerosis
      • Pain Disorders
      • Psychiatric Disorders
    • Oncology
    • Ophthalmology
    • Respiratory
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values and Culture
  • Support
    • Customer Support
    • In-Country Customer Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Get started
  1. Home Resources Downloads AI models for respiratory diseases from spirometry alone: validation based on UK Biobank

AI models for respiratory diseases from spirometry alone: validation based on UK Biobank

Read the publication here.

Rationale: AI can accurately diagnose respiratory diseases based on full lung function tests (Topalovic 2019). In primary care, often only spirometry with basic medical information (Age, Height, Weight, smoking history) is available. This study evaluates the ability of AI to diagnose respiratory diseases in primary care on a representative dataset (UK Biobank, UKBB) using spirometry. 

Methods: A Balanced Bagging Classifier model was trained on 1609 subjects who underwent lung function testing in a hospital, complemented with 500 healthy individuals from UKBB, then tested on an independent dataset extracted from UKBB. We included all physician-diagnosed patients with asthma, bronchiectasis, COPD and ILD that have acceptable quality spirometry done within a year before or after diagnosis and show, at least, subtle sign of abnormalities (FEV1/FVC Z-scores < -1 for obstructive diseases (Asthma, COPD, Bronchiectasis) and FEV1 Z-scores < -.5 for restrictive ones (ILD)). 

Results: The AI model achieved overall accuracy of 76%. Table 1 summarized sensitivity, specificity and PPV of the model across all disease categories. 

Conclusion: We show that when spirometry shows subtle abnormalities (either restrictive or obstructive), AI can accurately differentiate between major respiratory diseases. Such an AI model can be especially useful in primary care settings to help guide physicians towards the right diagnosis. 

Table1: Results of the AI model on UKBB test dataset 

 Number of test subjects Sensitivity Specificity PPV 
Asthma 1455 0.75 0.84 0.87 
Bronchiectasis 32 0.25 0.95 0.06 
COPD 473 0.71 0.93 0.70 
Healthy* 500 0.85 0.93 0.75 
ILD 27 0.70 0.98 0.31 

*500 individuals not included in training 

Authors: Ahmed Elmahy, Julie Maes, Paul Desbordes, Maarten De Vos, Marko Topalovic 

Download
Back to downloads
Share
Twitter Facebook LinkedIn

Latest Downloads

See all
Datasheet

Centralized FOT Services

Download icon Download icon
Download
White Paper

AI-enabled risk based monitoring – Cardiac Safety

Download icon Download icon
Download
White Paper

AI-enabled risk-based monitoring – Respiratory

Download icon Download icon
Download
Checklist

Top 5 questions biotech companies should ask to enable study success

Read icon Read icon
Read
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Get started

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.

Step 1 of 2 - Quick and easy to complete

Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2026 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum